2Massie BM,Shan NB.Evolving trends in the epidemiologic failure:Rationale for preventive strategies and comprehensive disease management[J].Am Hear J,1997,133:703-712.
3Carson PE.Beta Blocker treatment in heart failure[J].Prog Cardiovasc Dis,1999,41:301-322.
4Remme WJ,Swedberg K.Guidelines for the diagnosis and treatment of chronic heart failure[J].Eur Heart J,2001,22:1527-1560.
6Bisognano JD,Weinberger HD.Myocardial-directed overexpression of the human β-adrenergic receptor in transgenic mice[J].J Mol call cardiol,2000,32:817-830.
7Freeman K,Iaccarino G,Bohlmeyer T,et al.Overexpr-ession of theβ2 adrenergic receptor accelerates heart Failure in hypertrophic cardionmyopathy mice[J].Circulation,2000,100:Ⅰ-493.
8Packer M.Current role of beta-adrenegic blockers in the management of chronic heart failure[J].Am J Med,2001,110:81s-94s.
9Hjjar RJ,Monte F,Matsui T,et al.Prospect for gene therapy for heart failure[J].Cir Res,2000,86:616-621.
10CIBIS-Ⅱ Investigators and Committees.The Cardiac Insufficiency Bisoprolol Study Ⅱ(CIBIS-Ⅱ):a randomized trial[J].Lancet,1999,353:2001-2006.
